SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
CSL Behring Release: PRIMA Study Shows Treatment with Privigen® Improved Function in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)